Johnson & Johnson

JNJ · NYSE · USD

$256.03−1.02%−$2.63

Close · October 2, 2026

At a glance

Revenue growth: +6.05%; 2025 vs 2024
Net income growth: +90.56%; 2025 vs 2024
Net margin: 28.5%; 2024: 15.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	94,193	88,821	85,159	79,990	78,740	82,584	82,059	81,581	76,450	71,890
Cost of revenue	30,065	27,036	26,244	24,596	23,402	28,427	27,556	27,091	25,439	21,789
Gross profit	64,128	61,785	58,915	55,394	55,338	54,157	54,503	54,490	51,011	50,101
Selling, general and administrative	23,130	21,952	20,166	19,078	19,506	21,731	21,885	22,540	21,520	19,793
Research and development	14,665	17,232	15,085	14,135	14,277	12,159	11,355	10,775	10,594	9,143
Operating income	26,333	22,601	23,664	22,181	21,555	20,267	21,263	21,175	18,897	21,165
EBIT	26,333	22,601	23,664	22,181	21,555	20,267	21,263	21,175	18,897	21,165
EBITDA	33,836	29,940	30,767	28,510	28,206	27,498	28,272	28,104	24,539	24,919
Interest expense	971	755	772	276	183	201	318	1,005	934	726
Pre-tax income	32,581	16,687	15,062	19,359	19,178	16,497	17,328	17,999	17,673	19,803
Income tax	5,777	2,621	1,736	2,989	1,377	1,783	2,209	2,702	16,373	3,263
Net income	26,804	14,066	35,153	17,941	20,878	14,714	15,119	15,297	1,300	16,540
Net income to common shareholders	26,804	14,066	13,326	16,370	17,801	14,714	15,119	15,297	1,300	16,540
Basic EPS	11.13	5.84	5.26	6.24	6.76	5.59	5.72	5.70	0.48	6.04
Diluted EPS	11.03	5.79	5.20	6.14	6.66	5.51	5.63	5.61	0.47	5.93
Average shares (basic)	2,407	2,407	2,534	2,625	2,632	2,633	2,645	2,682	2,692	2,737
Average shares (diluted)	2,429	2,429	2,560	2,664	2,674	2,671	2,684	2,729	2,745	2,789
Dividend per share	5.14	4.91	4.70	4.45	4.19	3.98	3.75	3.54	3.32	3.15